|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.46 CAD | +2.95% |
|
+3.67% | +34.42% |
| 12-11 | Top Midday Gainers | MT |
| 12-11 | Fertilizer Shares Rise Following Report of Ukrainian Attack on Russian Plants | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 20.05B | 26.86B | 37.01B | 28.08B | 25.02B | |||||
Total Revenues | 20.05B | 26.86B | 37.01B | 28.08B | 25.02B | |||||
Cost of Goods Sold, Total | 14.81B | 17.45B | 21.59B | 19.61B | 17.49B | |||||
Gross Profit | 5.24B | 9.41B | 15.42B | 8.47B | 7.53B | |||||
Selling General & Admin Expenses, Total | 3.26B | 3.63B | 3.99B | 4.03B | 4.08B | |||||
Stock-Based Compensation (IS) | 69M | 198M | 63M | -14M | 37M | |||||
Other Operating Expenses | 393M | 737M | 1.53B | 907M | 816M | |||||
Other Operating Expenses, Total | 3.72B | 4.56B | 5.58B | 4.92B | 4.94B | |||||
Operating Income | 1.52B | 4.85B | 9.84B | 3.55B | 2.59B | |||||
Interest Expense, Total | -475M | -479M | -484M | -726M | -683M | |||||
Interest And Investment Income | 1M | 8M | 25M | 35M | 28M | |||||
Net Interest Expenses | -474M | -471M | -459M | -691M | -655M | |||||
Income (Loss) On Equity Invest. | 73M | 89M | 247M | 101M | 130M | |||||
Currency Exchange Gains (Loss) | -18M | -42M | -31M | -91M | -360M | |||||
Other Non Operating Income (Expenses) | -33M | 9M | -96M | -97M | -60M | |||||
EBT, Excl. Unusual Items | 1.07B | 4.43B | 9.5B | 2.78B | 1.65B | |||||
Restructuring Charges | - | - | - | - | -47M | |||||
Merger & Related Restructuring Charges | -60M | -43M | -46M | -49M | - | |||||
Gain (Loss) On Sale Of Investments | 250M | - | 19M | - | - | |||||
Gain (Loss) On Sale Of Assets | -6M | - | - | - | - | |||||
Asset Writedown | -824M | -33M | 780M | -774M | -530M | |||||
Insurance Settlements | - | - | - | - | 65M | |||||
Other Unusual Items | -48M | -187M | -8M | - | - | |||||
EBT, Incl. Unusual Items | 382M | 4.17B | 10.25B | 1.95B | 1.14B | |||||
Income Tax Expense | -77M | 989M | 2.56B | 670M | 436M | |||||
Earnings From Continuing Operations | 459M | 3.18B | 7.69B | 1.28B | 700M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 459M | 3.18B | 7.69B | 1.28B | 700M | |||||
Minority Interest | - | -26M | -27M | -24M | -26M | |||||
Net Income - (IS) | 459M | 3.15B | 7.66B | 1.26B | 674M | |||||
Net Income to Common Incl Extra Items | 459M | 3.15B | 7.66B | 1.26B | 674M | |||||
Net Income to Common Excl. Extra Items | 459M | 3.15B | 7.66B | 1.26B | 674M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.81 | 5.53 | 14.23 | 2.53 | 1.36 | |||||
Basic EPS - Continuing Operations | 0.81 | 5.53 | 14.23 | 2.53 | 1.36 | |||||
Basic Weighted Average Shares Outstanding | 570M | 570M | 538M | 496M | 494M | |||||
Net EPS - Diluted | 0.81 | 5.52 | 14.18 | 2.53 | 1.36 | |||||
Diluted EPS - Continuing Operations | 0.81 | 5.52 | 14.18 | 2.53 | 1.36 | |||||
Diluted Weighted Average Shares Outstanding | 570M | 571M | 540M | 497M | 494M | |||||
Normalized Basic EPS | 1.17 | 4.82 | 10.98 | 3.45 | 2.03 | |||||
Normalized Diluted EPS | 1.17 | 4.8 | 10.95 | 3.44 | 2.03 | |||||
Dividend Per Share | 1.8 | 1.84 | 1.92 | 2.12 | 2.16 | |||||
Payout Ratio | 224.4 | 33.14 | 13.46 | 82.03 | 157.27 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.23B | 6.49B | 11.51B | 5.33B | 4.51B | |||||
EBITA | 1.8B | 5.16B | 10.21B | 3.9B | 2.93B | |||||
EBIT | 1.52B | 4.85B | 9.84B | 3.55B | 2.59B | |||||
EBITDAR | 3.29B | 6.57B | 11.61B | 5.44B | 4.62B | |||||
Effective Tax Rate - (Ratio) | -20.16 | 23.73 | 24.98 | 34.32 | 38.38 | |||||
Total Current Taxes | -68M | 1.02B | 2.38B | 663M | 405M | |||||
Total Deferred Taxes | -9M | -31M | 182M | 7M | 31M | |||||
Normalized Net Income | 669M | 2.74B | 5.91B | 1.71B | 1B | |||||
Interest Capitalized | 20M | 29M | 37M | 71M | 82M | |||||
Interest on Long-Term Debt | 426M | 448M | 368M | 494M | 542M | |||||
Non-Cash Pension Expense | 16M | 19M | 16M | -67M | -1M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 2.81B | 3.14B | 3.41B | 3.4B | 3.44B | |||||
General and Administrative Expenses | 429M | 477M | 565M | 626M | 644M | |||||
Research And Development Expense From Footnotes | 39M | 69M | 122M | 114M | 124M | |||||
Net Rental Expense, Total | 60M | 81M | 93M | 103M | 110M | |||||
Imputed Operating Lease Interest Expense | 21.15M | 29.65M | 34.04M | 53.62M | 53.06M | |||||
Imputed Operating Lease Depreciation | 38.85M | 51.35M | 58.96M | 49.38M | 56.94M | |||||
Stock-Based Comp., Other (Total) | 69M | 198M | 63M | -14M | 37M | |||||
Total Stock-Based Compensation | 69M | 198M | 63M | -14M | 37M |
- Stock Market
- Equities
- NTR Stock
- Financials Nutrien Ltd.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















